Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.
Effect of CagriSema on body weight reduction and cardiometabolic risk factors in women by menopause status and hormone therapy use: A post hoc analysis of the REDEFINE 1 trial
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.